Tapinarof Under FDA Review for Treating Atopic Dermatitis
Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.
MDedge News
source https://www.medscape.com/s/viewarticle/topical-tapinarof-under-fda-review-new-indication-atopic-2024a100039i?src=rss
MDedge News
source https://www.medscape.com/s/viewarticle/topical-tapinarof-under-fda-review-new-indication-atopic-2024a100039i?src=rss
Comments
Post a Comment